Skip to main content

Extending Current Definitions of the Metabolic Syndrome

  • Chapter
Metabolic Syndrome and Diabetes

Abstract

Current interest in the concept of the metabolic syndrome (MS) dates back from the late 1980s, when Reaven, in his Banting Lecture at the American Diabetes Association, described a cluster of abnormalities, whose combined risk of developing future diabetes and cardiovascular risk (CVD) is greater than that of the risk of individual components. This cluster was termed “Syndrome X” by Reaven and later came to be known by various other names such as Metabolic Syndrome (MS) and Insulin Resistance Syndrome. The history of the concept of MS and its management are discussed elsewhere in this book. This chapter attempts to analyze the various definitions of MS currently in use and to establish the need to modify it for different ethnic groups and populations, based on currently available evidence.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607.

    Article  PubMed  CAS  Google Scholar 

  2. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80.

    Article  PubMed  CAS  Google Scholar 

  3. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–28.

    Article  PubMed  CAS  Google Scholar 

  4. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. The metabolic syndrome. Endocr Rev. 2008;29:777–822.

    Article  PubMed  CAS  Google Scholar 

  5. World Health Organisation. Definition diagnosis and classification of diabetes mellitus and its complications. Geneva: World Health Organization; 1999.

    Google Scholar 

  6. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetes Med. 1999;16:442–3.

    Article  CAS  Google Scholar 

  7. National Cholesterol Education Program Coordinating Committee. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421.

    Google Scholar 

  8. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet. 2005;366:1059–62.

    Article  PubMed  Google Scholar 

  9. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.

    Article  PubMed  Google Scholar 

  10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith Jr SC, International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.

    Article  PubMed  CAS  Google Scholar 

  11. WHO. Obesity: preventing and managing the global epidemic, Report of a WHOconsultation. World Health Organ Tech Rep Ser 894. Geneva, Switzerland: WHO; 2000.

    Google Scholar 

  12. World Health Organization. Obesity: preventing and managing the global epidemic: Report on a WHO Consultation (WHO Technical Report Series 894). Geneva, Switzerland: World Health Organization; 2000.

    Google Scholar 

  13. Health Canada. Canadian guidelines for body weight classification in adults. Ottawa, Canada: Health Canada Publications Centre; 2003. Publication ID No. 4645. ISBN 0-662-33431-0.

    Google Scholar 

  14. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL. ESC Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis. 2007;194:1–45.

    Article  PubMed  CAS  Google Scholar 

  15. Hara K, Matsushita Y, Horikoshi M, Yoshiike N, Yokoyama T, Tanaka H, Kadowaki T. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care. 2006;29:1123–4.

    Article  PubMed  Google Scholar 

  16. Oka R, Kobayashi J, Yagi K, Tanii H, Miyamato S, Asano A, Hagishita T, Mori M, Moriuchi T, Kobayashi M, Katsuda S, Kawashiri M, Nohara A, Takeda Y, Mabuchi H, Yamagishi M. Reassessment of the cutoff values of waist circumference and visceral fat for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract. 2008;79:474–81.

    Article  PubMed  Google Scholar 

  17. Zhou BF, Cooperative Meta-Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15:83–96.

    PubMed  Google Scholar 

  18. Parikh R, Mohan V, Joshi S. Should waist circumference be replaced by index of central obesity (ICO) in definition of metabolic syndrome? Diabetes Metab Res Rev. 2012;28:3–5.

    Article  PubMed  CAS  Google Scholar 

  19. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066–72.

    Article  PubMed  CAS  Google Scholar 

  20. Ingelsson E, Sullivan LM, Murabito JM, Fox CS, Benjamin EJ, Polak JF, Meigs JB, Keyes MJ, O'Donnell CJ, Wang TJ, D’Agostino Sr RB, Wolf PA, Vasan RS. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes. 2007;56:1718–26.

    Article  PubMed  CAS  Google Scholar 

  21. Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care. 2006;29:404–9.

    Article  PubMed  Google Scholar 

  22. Ford ES, Li C, Sattar N. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care. 2008;31(9):1898–904.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C, National Heart, Lung, and Blood Institute; American Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24:e13–8.

    Article  PubMed  CAS  Google Scholar 

  24. Cırık DA, Dilbaz B. What do we know about metabolic syndrome in adolescents with PCOS? J Turk Ger Gynecol Assoc. 2014;15:49–55.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Zhang P, Tian B. Metabolic syndrome: an important risk factor for Parkinson’s disease. Oxid Med Cell Longev. 2014;2014:729194.

    PubMed  PubMed Central  Google Scholar 

  26. Marcovecchio ML, Chiarelli F. Metabolic syndrome in youth: chimera or useful concept? Curr Diab Rep. 2013;13:56–62.

    Article  PubMed  Google Scholar 

  27. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362–74.

    Article  PubMed  CAS  Google Scholar 

  28. Invitti C, Maffeis C, Gilardini L, Pontiggia B, Mazzilli G, Girola A, Sartorio A, Morabito F, Viberti GC. Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. Int J Obes (Lond). 2006;30:627–33.

    Article  CAS  Google Scholar 

  29. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821–7.

    Article  PubMed  Google Scholar 

  30. Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Curr Diab Rep. 2004;4:53–62.

    Article  PubMed  Google Scholar 

  31. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28:2745–9.

    Article  PubMed  Google Scholar 

  32. Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr. 2004;145:445–51.

    Article  PubMed  Google Scholar 

  33. Vikram NK, Misra A, Pandey RM, Luthra K, Bhatt SP. Distribution and cutoff points of fasting insulin in Asian Indian adolescents and their association with metabolic syndrome. J Assoc Physicians India. 2008;56:949–54.

    PubMed  CAS  Google Scholar 

  34. Burns TL, Letuchy EM, Paulos R, Witt J. Childhood predictors of the metabolic syndrome in middle-aged adults: the Muscatine study. J Pediatr. 2009;155:S5.e17–26.

    Article  Google Scholar 

  35. Magnussen CG, Koskinen J, Chen W, Thomson R, Schmidt MD, Srinivasan SR, Kivimäki M, Mattsson N, Kähönen M, Laitinen T, Taittonen L, Rönnemaa T, Viikari JS, Berenson GS, Juonala M, Raitakari OT. Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study. Circulation. 2010;122:1604–11.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? J Pediatr. 2008;152:160–4.

    Article  PubMed  Google Scholar 

  37. Golley RK, Magarey AM, Steinbeck KS, Baur LA, Daniels LA. Comparison of metabolic syndrome prevalence using six different definitions in overweight pre-pubertal children enrolled in a weight management study. Int J Obes (Lond). 2006;30:853–60.

    Article  CAS  Google Scholar 

  38. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of WHO a Consultation. Part 1: diagnosis and classification of diabetes mellitus. Genebra; 1999.

    Google Scholar 

  39. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 285:2486e97.

    Google Scholar 

  40. Back Giuliano Ide C, Caramelli B, Pellanda L, Duncan B, Mattos S, et al. I guidelines of prevention of atherosclerosis in childhood and adolescence. Arq Bras Cardiol. 2005;85 Suppl 6:4–36.

    PubMed  Google Scholar 

  41. Himes JH, Dietz WH. Guidelines for overweight in adolescent preventive services: recommendations from an expert committee. The Expert Committee on Clinical Guidelines for Overweight in Adolescent Preventive Services. Am J Clin Nutr. 1994;59:307–16.

    PubMed  CAS  Google Scholar 

  42. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat. 2002;11(246):1–190.

    Google Scholar 

  43. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460–8.

    Article  PubMed  CAS  Google Scholar 

  44. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494–7.

    Article  PubMed  Google Scholar 

  45. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S, International Diabetes Federation Task Force on Epidemiology and Prevention of Diabetes. The metabolic syndrome in children and adolescents. Lancet. 2007;369:2059–61.

    Article  PubMed  Google Scholar 

  46. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter? Circulation. 2007;115:1806–10.

    Article  PubMed  Google Scholar 

  47. Indulekha K, Surendar J, Mohan V. High sensitive C-reactive protein, tumor necrosis factor-alpha, interleukin-6 and vascular cell adhesion molecule levels in Asian Indians with metabolic syndrome and insulin resistance (CURES – 105). J Diabetes Sci Technol. 2011;5:982–8.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Grundy SM. Does a diagnosis of metabolic syndrome have value in clinical practice? Am J ClinNutr. 2006;83:1248–51.

    CAS  Google Scholar 

  49. Eisenmann JC. On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol. 2008;7:17.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Nilsson PM, Engström G, Hedblad B. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects – a population-based study comparing three different definitions. Diabetes Med. 2007;24:464–72.

    Article  CAS  Google Scholar 

  51. Butler J, Rodondi N, Zhu Y, Figaro K, Fazio S, Vaughan DE, Health ABC Study, et al. Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol. 2006;47:1595–602.

    Article  PubMed  Google Scholar 

  52. Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes. 2004;53:1068–73.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Mohan M.D., F.R.C.P., Ph.D., D.Sc. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Indulekha, K., Unnikrishnan, R., Mohan, V. (2016). Extending Current Definitions of the Metabolic Syndrome. In: Kurian, M., Wolfe, B., Ikramuddin, S. (eds) Metabolic Syndrome and Diabetes. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3220-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3220-7_2

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3219-1

  • Online ISBN: 978-1-4939-3220-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics